EH
PACB icon

Equitable Holdings’s Pacific Biosciences PACB Stock Holding History

Equitable Holdings’s Portfolio PACB Stock Details PACB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-11,500
Closed -$14.7K – 1641
2025
Q3 		$14.7K Sell
11,500
-10,375
-47% -$14.1K ﹤0.01% 1523
2025
Q2 		$27.1K Hold
21,875
– – ﹤0.01% 1447
2025
Q1 		$25.8K Hold
21,875
– – ﹤0.01% 1328
2024
Q4 		$40K Buy
+21,875
New +$42.7K ﹤0.01% 1255

Other funds holding PACB

AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SoftBank Group
SoftBank Group Tokyo, Japan $18.2B AUM 177.65% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Equitable Holdings's PACB Position: Q4 2025 in Review

Equitable Holdings sold out of Pacific Biosciences (PACB) in Q4 2025, closing a stake of 11,500 shares — an estimated $14.7K sold.

Equitable Holdings first reported a position in PACB in Q4 2024 and held it in 4 quarters. The position peaked at $40K in Q4 2024. 215 funds tracked by Wall St. Rank hold PACB as of Q4 2025.

  • Equitable Holdings reported no remaining Pacific Biosciences position as of Q4 2025 after selling out during the quarter.
  • Equitable Holdings sold 11,500 Pacific Biosciences shares in Q4 2025, an estimated $14.7K.
  • Equitable Holdings first reported a position in Pacific Biosciences in Q4 2024 and held it in 4 quarters.
  • Equitable Holdings's Pacific Biosciences position peaked at $40K in Q4 2024.
  • 215 funds tracked by Wall St. Rank held Pacific Biosciences as of Q4 2025.

Based on Equitable Holdings's 13F filing for Q4 2025, filed 17 Feb 2026.